Skip to main content
Equibles

Freestone Capital Holdings, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1470876 Seattle, WA
Back to REGN Full portfolio

Position in REGN

as of Jun 30, 2026 · filed Jul 31, 2026
Position Value
$563,680
+$205,176 QoQ
Shares Held
904
+94.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#780
of 1,329 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Freestone Capital Holdings, LLC holds $7,262,289 across 14 Biotechnology names. REGN ranks #4 (7.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABUS
Arbutus Biopharma Corp
 442,500 $2,124,000
2 IMNM
Immunome Inc.
 60,589 $1,283,880
3 BNTX
BioNTech SE
 7,914 $736,397
4 REGN
Regeneron Pharmaceuticals, Inc.
This page 		904 $563,680
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,004 $498,716
6 RYTM
Rhythm Pharmaceuticals, Inc.
 3,700 $410,811
7 RVMD
Revolution Medicines, Inc.
 2,109 $394,973
8 EXEL
Exelixis, Inc.
 6,974 $379,455

All Filings in REGN

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $563,680 904
2026-03-31 $358,504 464
2025-12-31 $358,919 465
2025-09-30 $261,455 465
2025-06-30 $244,125 465
2025-03-31 $341,215 538
2024-12-31 $442,356 621
2024-09-30 $643,358 612
2024-06-30 $636,924 606
2024-03-31 $569,794 592